SHARE
Covid 19 Drug Delivery Devices Market

COVID-19 Drug Delivery Devices - Global Market Outlook (2019-2027)

4.6 (95 reviews)
Published: November 2020 ID: SMRC20149
4.6 (95 reviews)
Published: November 2020 ID: SMRC20149

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global COVID-19 Drug Delivery Devices Market is accounted for $2.07 billion in 2019 and is expected to reach $4.47 billion by 2027 growing at a CAGR of 10.1% during the forecast period. Competitive race among the healthcare companies and drastic surge in drug development due to the COVID-19 outbreak are the major factors driving the market growth. However, high manufacturing cost of COVID-19 drug delivery devices is restraining the market growth.

Slide81_400x200.png

COVID-19 Drug Delivery Devices are engineered technologies for efficient drug delivery and/or release of therapeutic agents in the circulatory system and drug movement through cells and tissues for the prevention of COVID-19. Drug delivery devices control the rate at which a drug is released and the location in the body where it is released.  Some systems can control both the tasks. 

Based on route of administration, the parenteral segment is likely to have a huge demand. Novel biologics such as RNA and DNA-based vaccines, recombinant nano particles, and monoclonal antibodies are currently being explored in clinical trials. Such biologics can only be administered intravenously as they are degraded when given orally. Currently, about 10 potential COVID-19 vaccine candidates have entered the clinical trials, most of which are to be administered via a parenteral route of administration.

By geography, North America is going to have a lucrative growth during the forecast period. North America has a well-established healthcare infrastructure and a large number of key pharmaceutical companies. It is a developed economy with high disposable income, which enables people to choose from various advanced treatment options. In the U.S., a collaborative framework was established by an initiative named Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV).

Some of the key players profiled in the COVID-19 Drug Delivery Devices Market include AstraZeneca, Bharat Biotech, GlaxoSmithKline Plc, Johnson & Johnson, Moderna, Novawax Inc, Pfizer, PharmaJet and Serum Institute of India.

Route of Administrations Covered:
• Dermal
• Nasal
• Parenteral

Distribution Channels Covered:
• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies   

Products Covered:
• Inhalers
• Needle Free Injectors
• Patches
• Prefilled Syringe

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary   
     
2 Preface   
 
 2.1 Abstract   
 2.2 Stake Holders  
 2.3 Research Scope  
 2.4 Research Methodology 
  2.4.1 Data Mining 
  2.4.2 Data Analysis 
  2.4.3 Data Validation 
  2.4.4 Research Approach 
 2.5 Research Sources  
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions 
     
3 Market Trend Analysis  
 3.1 Introduction  
 3.2 Drivers   
 3.3 Restraints  
 3.4 Opportunities  
 3.5 Threats   
 3.6 Product Analysis  
 3.7 Emerging Markets  
 3.8 Impact of Covid-19  
     
4 Porters Five Force Analysis  

 4.1 Bargaining power of suppliers 
 4.2 Bargaining power of buyers 
 4.3 Threat of substitutes 
 4.4 Threat of new entrants 
 4.5 Competitive rivalry  
     
5 Global COVID-19 Drug Delivery Devices Market, By Route of Administration
 5.1 Introduction  
 5.2 Dermal   
 5.3 Nasal   
 5.4 Parenteral  
     
6 Global COVID-19 Drug Delivery Devices Market, By Distribution Channel
 6.1 Introduction  
 6.2 Retail Pharmacies  
 6.3 Online Pharmacies  
 6.4 Hospital Pharmacies 
     
7 Global COVID-19 Drug Delivery Devices Market, By Product
 7.1 Introduction  
 7.2 Inhalers   
 7.3 Needle Free Injectors 
 7.4 Patches   
 7.5 Prefilled Syringe  
     
8 Global COVID-19 Drug Delivery Devices Market, By Geography
 8.1 Introduction  
 8.2 North America  
  8.2.1 US  
  8.2.2 Canada  
  8.2.3 Mexico  
 8.3 Europe   
  8.3.1 Germany  
  8.3.2 UK  
  8.3.3 Italy  
  8.3.4 France  
  8.3.5 Spain  
  8.3.6 Rest of Europe 
 8.4 Asia Pacific  
  8.4.1 Japan  
  8.4.2 China  
  8.4.3 India  
  8.4.4 Australia  
  8.4.5 New Zealand 
  8.4.6 South Korea 
  8.4.7 Rest of Asia Pacific 
 8.5 South America  
  8.5.1 Argentina 
  8.5.2 Brazil  
  8.5.3 Chile  
  8.5.4 Rest of South America
 8.6 Middle East & Africa 
  8.6.1 Saudi Arabia 
  8.6.2 UAE  
  8.6.3 Qatar  
  8.6.4 South Africa 
  8.6.5 Rest of Middle East & Africa
     
9 Key Developments   
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers 
 9.3 New Product Launch 
 9.4 Expansions  
 9.5 Other Key Strategies 
     
10 Company Profiling   
 10.1 AstraZeneca  
 10.2 Bharat Biotech  
 10.3 GlaxoSmithKline Plc 
 10.4 Johnson & Johnson  
 10.5 Moderna   
 10.6 Novawax Inc  
 10.7 Pfizer   
 10.8 PharmaJet  
 10.9 Serum Institute of India 


List of Tables    
1 Global COVID-19 Drug Delivery Devices Market Outlook, By Region (2018-2027) ($MN)
2 Global COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
3 Global COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
4 Global COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
5 Global COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
6 Global COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
7 Global COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
8 Global COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
9 Global COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
10 Global COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
11 Global COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
12 Global COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
13 Global COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
14 Global COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
15 North America COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
16 North America COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
17 North America COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
18 North America COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
19 North America COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
20 North America COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
21 North America COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
22 North America COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
23 North America COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
24 North America COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
25 North America COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
26 North America COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
27 North America COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
28 North America COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
29 Europe COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
30 Europe COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
31 Europe COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
32 Europe COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
33 Europe COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
34 Europe COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
35 Europe COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
36 Europe COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
37 Europe COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
38 Europe COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
39 Europe COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
40 Europe COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
41 Europe COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
42 Europe COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
43 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
44 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
45 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
46 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
47 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
48 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
49 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
50 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
51 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
52 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
53 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
54 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
55 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
56 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
57 South America COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
58 South America COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
59 South America COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
60 South America COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
61 South America COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
62 South America COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
63 South America COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
64 South America COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
65 South America COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
66 South America COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
67 South America COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
68 South America COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
69 South America COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
70 South America COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
71 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
72 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
73 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
74 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
75 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
76 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
77 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
78 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
79 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
80 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
81 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
82 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
83 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
84 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials